GenAI models demonstrate high accuracy and consistency in pathological grading and risk assessment for lung adenocarcinoma.
Key Details
- 1Study tested GPT-4o, Claude-3.5-Sonnet, and Gemini-1.5-Pro on 492 digitized slides from public and independent sources.
- 2Claude-3.5-Sonnet achieved 82.3% accuracy in lung adenocarcinoma grading, with strong repeatability.
- 3Models extracted 11 histological features and 4 clinical variables for comprehensive risk assessment.
- 4Diagnostic and prognostic tasks were completed in minutes, much faster than human experts.
- 5AI models reduced inter-observer variability and enabled objective, standardized analysis across multiple samples.
- 6GenAI models surfaced new significant prognostic factors including interstitial fibrosis and papillary patterns.
Why It Matters
This breakthrough underscores the transformative potential of generative AI in digital pathology, promising faster, standardized, and potentially more insightful cancer diagnosis and prognosis translation. Such advances could boost accuracy in resource-limited settings and improve reproducibility in pathological assessments, reshaping clinical workflows.
Source
EurekAlert
Related News
•EurekAlert
University of Michigan AI Achieves Near-Instant Brain MRI Diagnosis
University of Michigan's AI model, Prima, can diagnose brain MRI scans in seconds, achieving up to 97.5% accuracy in identifying neurological conditions.
•EurekAlert
BrainIAC AI Model Excels in Brain MRI Analysis and Disease Prediction
BrainIAC, a new foundation model from Mass General Brigham, outperforms traditional AI approaches in analyzing brain MRI for tasks like brain age estimation and cancer prognosis.
•EurekAlert
Janus Meta-Imager Leverages Neural Networks for Asymmetric Optical Imaging
Researchers unveil a passive all-optical device using neural networks for asymmetric image transmission and transformation.